| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 3,200 | 1,600 | 1,600 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 4921 | 1,323,729 | 2,327,886 |
| INVESTMENT - UBS 6772 | 420,976 | 419,483 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN APPLIED STEMCELL INC | AT COST | 52,500 | 52,500 |
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA LLC | 22,771 | -32,295 | -32,295 |
| 7 HILLS PHARMA LLC - CONVERTIBLE NOTE | 101,424 | 101,424 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA, LLC | -55,066 | -55,066 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 460 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 21,596 | 21,596 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 353 | 353 | 0 | |
| FEDERAL TAXES | 165 | 0 | 0 |